PROTAC B-Raf degrader 1
PROTAC B-Raf degrader 1 (compound 2) is a proteolysis targeting chimera (PROTAC) for the degradation of B-Raf based on Cereblon ligand with anti-cancer activity[1].
Product Specifications
CAS Number
[2364367-27-9]
UNSPSC
12352005
Target
PROTACs; Raf
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/PROTAC_B-Raf_degrader_1.html
Purity
99.78
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
O=C(NC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O)CNC(CNC4=CC(CS(=O)(/C=C/C5=C(OC)C=C(OC)C=C5OC)=O)=CC=C4OC)=O
Molecular Formula
C36H37N5O12S
Molecular Weight
763.77
References & Citations
[1]Chen H, et al. Pomalidomide hybrids act as proteolysis targeting chimeras: Synthesis, anticancer activity and B-Raf degradation. Bioorg Chem. 2019 Mar 19;87:191-199.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
B-Raf
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
C2086-71W 50 µg
Caspase 2 (Caspase-2 Apoptosis-related Cysteine Protease, CASP 2, CASP2, CASP-2, ICH 1, ICH1, ICH-1 Protease, ICH 1L, ICH-1L, ICH 1L/1S, ICH-1L/1S, Neural Precursor Cell Expressed Developmentally Down-regulated 2, NEDD 2, NEDD2, NEDD-2 Apoptosis Regulatory Gene) discontinued. see C2086-72G
Ask
View Details